The current financial score of Sotera Health Co is 8.49. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 321.38M, representing a year-over-year increase of 9.18%, while its net profit experienced a year-over-year increase of 573.82%.
The current valuation score of Sotera Health Co is 6.98. Its current P/E ratio is 45.18, which is 340.88% below the recent high of 199.18 and 149.58% above the recent low of -22.40.
The current earnings forecast score of Sotera Health Co is 8.36. The average price target is 23.33, with a high of 25.00 and a low of 22.00.
The current price momentum score of Sotera Health Co is 3.24. Currently, the stock price is trading between the resistance level at 19.64 and the support level at 17.92, making it suitable for range-bound swing trading.
The current institutional shareholding score of Sotera Health Co is 10.00. The latest institutional shareholding proportion is 94.60%, representing a quarter-over-quarter increase of 17.95%. The largest institutional shareholder is Joel Greenblatt, holding a total of 2.21M shares, representing 0.09% of shares outstanding, with 96.05% increase in holdings.
The current risk assessment score of Sotera Health Co is 8.29. The company's beta value is 1.85. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.